Carmel Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Carmel Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-456	Closed	-$231K	–	642
2023 Q3	$231K	Buy	456 +234	+105%	+$125K	0.1%	138
2023 Q2	$116K	Sell	222 -252	-53%	-$136K	0.06%	159
2023 Q1	$273K	Sell	474 -112	-19%	-$63.1K	0.16%	104
2022 Q4	$322K	Sell	586 -20	-3%	-$10.6K	0.22%	92
2022 Q3	$307K	Buy	606 +2	+0.3%	+$1.12K	0.3%	80
2022 Q2	$328K	Hold	604	–	–	0.31%	76
2022 Q1	$357K	Sell	604 -6	-1%	-$3.45K	0.3%	76
2021 Q4	$407K	Buy	+610	New	+$381K	0.3%	68

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Carmel Capital Partners's TMO Position: Q4 2023 in Review

Carmel Capital Partners sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 456 shares — an estimated $231K sold.

Carmel Capital Partners first reported a position in TMO in Q4 2021 and held it in 8 quarters. The position peaked at $407K in Q4 2021. 2,490 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

Carmel Capital Partners reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
Carmel Capital Partners sold 456 Thermo Fisher Scientific shares in Q4 2023, an estimated $231K.
Carmel Capital Partners first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 8 quarters.
Carmel Capital Partners's Thermo Fisher Scientific position peaked at $407K in Q4 2021.
2,490 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Carmel Capital Partners's 13F filing for Q4 2023, filed 1 Feb 2024.